See more : FAWER Automotive Parts Limited Company (000030.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Mangoceuticals, Inc. (MGRX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mangoceuticals, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- Cargosol Logistics Limited (CARGOSOL.BO) Income Statement Analysis – Financial Results
- Golden Cross Resources Limited (GCR.AX) Income Statement Analysis – Financial Results
- BV Financial, Inc. (BVFL) Income Statement Analysis – Financial Results
- Henan Hengxing Science & Technology Co.,Ltd. (002132.SZ) Income Statement Analysis – Financial Results
- Qingdao Citymedia Co,. Ltd. (600229.SS) Income Statement Analysis – Financial Results
Mangoceuticals, Inc. (MGRX)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.mangorx.com
About Mangoceuticals, Inc.
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 731.49K | 8.94K | 0.00 |
| Cost of Revenue | 299.99K | 4.09K | 0.00 |
| Gross Profit | 431.50K | 4.85K | 0.00 |
| Gross Profit Ratio | 58.99% | 54.26% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.45M | 2.00M | 70.08K |
| Selling & Marketing | 2.10M | 352.86K | -52.56K |
| SG&A | 8.55M | 2.00M | 17.52K |
| Other Expenses | 1.10M | 0.00 | 0.00 |
| Operating Expenses | 9.65M | 2.00M | 17.52K |
| Cost & Expenses | 9.95M | 2.00M | 17.52K |
| Interest Income | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 6.47K | 181.00 |
| Depreciation & Amortization | 24.89K | 3.86K | 70.08K |
| EBITDA | -9.19M | -1.99M | 52.56K |
| EBITDA Ratio | -1,256.00% | -22,236.48% | 0.00% |
| Operating Income | -9.22M | -1.99M | -17.52K |
| Operating Income Ratio | -1,260.28% | -22,279.70% | 0.00% |
| Total Other Income/Expenses | 6.47K | -6.47K | -53.28K |
| Income Before Tax | -9.21M | -2.00M | -17.70K |
| Income Before Tax Ratio | -1,259.40% | -22,352.11% | 0.00% |
| Income Tax Expense | 0.00 | -224.62K | -70.08K |
| Net Income | -9.21M | -2.00M | -17.70K |
| Net Income Ratio | -1,259.40% | -22,352.11% | 0.00% |
| EPS | -6.45 | -0.12 | 0.00 |
| EPS Diluted | -6.45 | -0.12 | 0.00 |
| Weighted Avg Shares Out | 1.43M | 17.32M | 17.32M |
| Weighted Avg Shares Out (Dil) | 1.43M | 17.32M | 17.32M |
Mangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin America
Tapping into a market of more than 40,000 pharmacies, retail outlets, and convenience stores across Mexico in 2024 and fueling International Sales Access Across Latin America
Mangoceuticals Selects TRYBE Labs as its Nationwide Blood Collection and Testing Services Provider
TRYBE Labs to provide MangoRx customers with turnkey at-home blood collection services and solutions Dallas, Texas, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety...
Mangoceuticals Expands its Men's Health Product Line with Compounded Hair Growth Treatment 'Grow' by MangoRx
DALLAS, TX / ACCESSWIRE / November 16, 2023 / Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely...
Mangoceuticals, Inc. Launches Charitable Initiative in Support of Men's Health Awareness Month
Dallas, Texas, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely...
Mangoceuticals Launches TikTok Influencer Initiative and Becomes the Presenting Sponsor of the Only Stans Podcast with Glenny Balls
Announcement follows launch of Affiliate Program to Drive Further Awareness and Growth Dallas, Texas, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men's health...
Mangoceuticals Announces TV Air Dates for Interview Featuring CEO Jacob Cohen on Bloomberg TV and Fox Business
Dallas, Texas, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated...
Mangoceuticals Announces the Official Launch of MangoRx Affiliate Marketing Program to Enhance and Accelerate Topline Growth
Dallas, Texas, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated...
Mangoceuticals Launches New High-Production Quality Ad Providing Fresh Insight into its Proprietary Mango Erectile Dysfunction Pill Formula
Dallas, Texas, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated...
Mangoceuticals Launches New Sildenafil Based Erectile Dysfunction Product with Signature Mango Flavor & Rapid Dissolve
Dallas, Texas, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated...
Mangoceuticals Engaged by Social Media Sensation Adam22 as Exclusive New Sponsor of Hit Podcasts with Skyrocketing Male Engagement
Dallas, Texas, July 18, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated...
Source: https://incomestatements.info
Category: Stock Reports